To identify critical SENP6 targets that potentially mediate its tumor-suppressive role in BCL, we scrutinized two recent proteomics studies that defined SENP6 targets (Supplementary Fig. 10a)23,25. The gene discussed is SENP6; the disease is neoplasm.